Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Onyvax begins clinical trials for colorectal cancer vaccines

June 15, 2000

Immunomedics reports phase II results of CEA-Cide as colorectal cancer therapy

June 7, 2000

Progenics to continue GMK cancer vaccine trial as an extension study

June 2, 2000

CPMP recommends approval of Herceptin for treatment of metastatic breast cancer

May 29, 2000

Single doses of HspE7 are well tolerated and elicit specific cell-mediated immunity

May 29, 2000

New fusion toxin with therapeutic potential in acute-phase CML presented at ASCO

May 29, 2000

Phase I trial of Hu1D10 continues following positive results in first lymphoma patients treated

May 29, 2000

Antisoma temporarily halts Theragyn phase III enrollment

May 29, 2000

News from ASCO: Medarex's MDX-210 may be useful in breast cancer and ovarian cancer

May 26, 2000

Vaccination with ras peptides as therapeutic strategy in pancreatic cancer

May 26, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...